Food and Drug Regulations (C.R.C., c. 870)
Full Document:
Regulations are current to 2012-05-14 and last amended on 2012-05-13. Previous Versions
SCHEDULE
(Section J.01.001)
| 1. | The following amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues: | |
| (1) | N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine) | |
| (2) | 4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine) | |
| (3) | 3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine) | |
| (4) | 2,5-dimethoxyamphetamine(2,5-dimethoxy-α-methylbenzeneethanamine) | |
| (5) | 4-methoxyamphetamine (4-methoxy-α-methylbenzeneethanamine) | |
| (6) | 2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzeneethanamine) | |
| (7) | N-methyl-3,4-methylenedioxyamphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine) | |
| (8) | 4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine) | |
| (9) | 5-methoxy-3,4-methylenedioxyamphetamine (7-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine) | |
| (10) | N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine) | |
| (11) | N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine) | |
| (12) | 4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine) | |
| (13) | 4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine) | |
| (14) | 4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methylbenzeneethanamine) | |
| (15) | 4-ethoxyamphetamine (4-ethoxy-α-methyl-benzeneethanamine) | |
| (16) | N-Propyl-3,4-methylenedioxyamphetamine (α-methyl-N-propyl-1,3-benzodioxole-5-ethanamine) | |
| (17) | N-hydroxy-3,4-methylenedioxyamphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine) | |
| (18) | 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzeneethanamine) | |
| 2. | Lysergic acid diethylamide (LSD) (N,N-diethyllysergamide) and any salt thereof | |
| 3. | N,N-Diethyltryptamine (DET) (3-[(2-diethylamino)ethyl]indole) and any salt thereof | |
| 4. | N,N-Dimethyltryptamine (DMT) (3-[(2-dimethylamino)ethyl]indole) and any salt thereof | |
| 5. | N-Methyl-3-piperidyl benzilate (LBJ) (3-[(hydroxydiphenylacetyl)oxy]-1-methylpiperidine) and any salt thereof | |
| 6. | Harmaline (4,9-dihydro-7-methoxy-1-methyl-3H-pyrido(3,4-b)indole) and any salt thereof | |
| 7. | Harmalol (4,9-dihydro-1-methyl-3H-pyrido(3,4-ß)indol-7-ol) and any salt thereof | |
| 8. | Psilocin (3-[2-(dimethylamino)ethyl]-4-hydroxyindole) and any salt thereof | |
| 9. | Psilocybin (3-[2-(dimethylamino)ethyl]-4-phosphoryloxyindole) and any salt thereof | |
| 10. | N-(1-phenylcyclohexyl)ethylamine (PCE) and any salt thereof | |
| 11. | 1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) and any salt thereof | |
| 12. | 1-Phenyl-N-propylcyclohexanamine and any salt thereof | |
| 13. | Mescaline (3,4,5-trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora) | |
| 14. | 4-Methylaminorex (4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) and any salt thereof | |
| 15. | 2-Methylamino-1-phenyl-1-propanone and any salt thereof | |
| 16. | 1-[1-(Phenylmethyl)cyclohexyl]piperidine and any salt thereof | |
| 17. | 1-[1-(4-Methylphenyl)cyclohexyl]piperidine and any salt thereof | |
| 18. | Etryptamine (3-(2-aminobutyl)indole) and any salt thereof | |
| 19. | Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof | |
| 20. | Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers | |
| 21. | Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers | |
- SOR/97-228, s. 25;
- SOR/2003-34, ss. 4, 5;
- SOR/2012-65, s. 1.